News
BDXB
48.16
0.00%
0.00
UPDATE 1-Becton Dickinson lowers 2026 profit forecast, shares fall
Reuters · 2h ago
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Playboy, Ciena
Reuters · 2h ago
UPDATE 1-Waters forecasts weak first-quarter profit, shares slide
Reuters · 4h ago
BUZZ-U.S. STOCKS ON THE MOVE-Edgewell, Waters Corp, Dynatrace
Reuters · 5h ago
Waters forecasts first-quarter profit below Wall Street estimates, shares slide
Reuters · 6h ago
BUZZ-U.S. STOCKS ON THE MOVE- Once Upon a Farm, Emerson, Momentus
Reuters · 7h ago
BD schließt Zusammenschluss von Biosciences & Diagnostic Solutions mit Waters ab
Reuters · 7h ago
Waters übernimmt BD Biosciences und Diagnostic Solutions
Reuters · 7h ago
Waters Completes Combination with BD's Biosciences and Diagnostic Solutions Businesses
Reuters · 7h ago
CORRECTED-Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit
Reuters · 7h ago
Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit
Reuters · 7h ago
WATERS COMPLETES COMBINATION WITH BD'S BIOSCIENCES & DIAGNOSTIC SOLUTIONS BUSINESSES
Reuters · 7h ago
BUZZ-Becton Dickinson falls after lowering 2026 profit forecast
Reuters · 9h ago
Becton Dickinson Q1 revenue beats on Connected Care segment strength
Reuters · 9h ago
BD: AFFIRMS FY26 REVENUE GROWTH GUIDANCE
Reuters · 10h ago
BD REPORTS FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS
Reuters · 10h ago
BD Files Initial Statement of Beneficial Ownership for EVP & Chief ISC Officer Massimiliano Urbini
Reuters · 3d ago
BD Issues Series D Preferred Shares in Private Placement
Reuters · 4d ago
BD kündigt Privatplatzierung von Vorzugsaktien an
Reuters · 4d ago
BD Held Annual Shareholder Meeting
Reuters · 01/30 21:18
More
Webull provides a variety of real-time BDXB stock news. You can receive the latest news about Becton Dickinson And Co through multiple platforms. This information may help you make smarter investment decisions.
About BDXB
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.